Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management

I Savelieva, AJ Camm - Journal of Interventional Cardiac …, 2000 - Springer
Although first described about 100yr ago, atrial fibrillation (AF) is now recognized as the
most common of all arrhythmias. It has a substantial morbidity and presents a considerable …

Early management of atrial fibrillation to prevent cardiovascular complications

S Nattel, E Guasch, I Savelieva, FG Cosio… - European heart …, 2014 - academic.oup.com
Atrial fibrillation (AF) is generally considered a progressive disease, typically evolving from
paroxysmal through persistent to ‘permanent’ forms, a process attributed to electrical and …

Current concepts in the pathogenesis of atrial fibrillation

A Kourliouros, I Savelieva, A Kiotsekoglou… - American heart …, 2009 - Elsevier
Current evidence suggests that the pathogenesis of atrial fibrillation (AF) is multifactorial.
The observation that AF, once present, alters the electrophysiologic properties of the atrial …

Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a …

G Boriani, I Savelieva, GA Dan, JC Deharo… - Ep …, 2015 - academic.oup.com
The kidney exerts multiple functions, and pathophysiological interactions between the kidney
and the heart have important clinical implications, but it has only recently become clear that …

Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific …

…, M Malik, J Poole, T Potpara, I Savelieva… - Ep …, 2018 - academic.oup.com
There is an increasing awareness that sex is a major determinant of the incidence, aetiology,
and clinical presentation of arrhythmias, and that there are sex differences in access and …

Frailty in cardiology: definition, assessment and clinical implications for general cardiology. A consensus document of the council for cardiology practice (CCP) …

…, C Lionis, A Abreu, I Savelieva… - European journal of …, 2022 - academic.oup.com
Frailty is a health condition leading to many adverse clinical outcomes. The relationship
between frailty and advanced age, multimorbidity and disability has a significant impact on …

Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of …

…, T Potpara, BK Poulsen, M Saba, I Savelieva… - Ep …, 2018 - academic.oup.com
NSAT Non-sustained atrial tachycardia NSVT Non-sustained ventricular tachycardia PD
Pharmacodynamic P-GP P-glucoprotein PK Pharmacokinetic PM Pacemaker PVT Polymorphic …

If Inhibition with Ivabradine: Electrophysiological Effects and Safety

I Savelieva, AJ Camm - Drug safety, 2008 - Springer
Ivabradine belongs to a new class of specific heart rate reducing agents that inhibit
spontaneous pacemaker activity of the sinus node by selectively and specifically inhibiting the I f …

Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches

I Savelieva, J Camm - Europace, 2008 - academic.oup.com
By 2050, atrial fibrillation (AF) will be present in 2% of the general population and in a far
higher proportion of elderly patients. Currently, we are content with rate control and …

Update on atrial fibrillation: part I

I Savelieva, J Camm - … Indexed and Peer‐Reviewed Journal for …, 2008 - Wiley Online Library
Atrial fibrillation (AF) is an epidemic, affecting 1% to 1.5% of the population in the developed
world. Projected data from the population‐based studies suggest that the prevalence of AF …